Corbus Pharma Rewards CMO with Zero‑Cost RSU & Option Awards Amid Executive Sell‑Offs, Hinting at Confidence in Lenabasum Pipeline
Corbus Pharmaceuticals’ insider moves show CMO Nicacio Viana’s new RSU and option grants signal strong confidence in the company’s lenabasum pipeline and future growth.
- CORBUS PHARMACEUTICALS HOLDI
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- AI generated
3 minutes to read